Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Comparative validity of accelerometer based measures of physical activity for people with multiple sclerosis.
Therapeutic effet of phase ii enzyme inducers in experimental allergic encephalomyelitis (eae).
The therapeutic potential of cannabis and cannabinoids.
Identification and quantification of the basal and inducible Nrf2-dependent proteomes in mouse liver: Biochemical, pharmacological and toxicological implications.
Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis.
Diagnostic laboratory testing for Charcot Marie Tooth disease (CMT): the spectrum of gene defects in Norwegian patients with CMT and its implications for future genetic test strategies.
Passive induction of experimental allergic encephalomyelitis.
Oligodendrocyte progenitor cell susceptibility to injury in multiple sclerosis.
Effect of stress on brain inflammation and multiple sclerosis.
Fine Mapping and Functional Analysis of the Multiple Sclerosis Risk Gene CD6.
Differential gene expression in LPS/IFNgamma activated microglia and macrophages: in vitro versus in vivo.
Reduced gamma-aminobutyric acid concentration is associated with physical disability in progressive multiple sclerosis.
Prolonged-release fampridine in multiple sclerosis: Improved ambulation effected by changes in walking pattern.
Biological and nonbiological complex drugs for multiple sclerosis in Latin America: regulations and risk management.
Endogenous opioid inhibition of proliferation of T and B cell subpopulations in response to immunization for experimental autoimmune encephalomyelitis.
Interplaying factors that effect multiple sclerosis causation and sustenance.
ApoTransferrin: Dual Role on Adult Subventricular Zone-Derived Neurospheres.
Viruses and Multiple Sclerosis.
Segmentation of Multiple Sclerosis Lesions in Brain MR Images Using Spatially Constrained Possibilistic Fuzzy C-Means Classification.
Differential effect of baclofen on cortical and spinal inhibitory circuits.
New-onset type 1 diabetes mellitus and anti-aquaporin-4 antibody positive optic neuritis associated with type 1 interferon therapy for chronic hepatitis C.
Retinal architecture and mfERG: Optic nerve head component response characteristics in MS.
FTY720 (Fingolimod) attenuates basal and sphingosine 1-phosphate-evoked thyroid cancer cell invasion.
Bilateral Vision Loss Responsive to Corticosteroids.
Discovery and initial verification of differentially abundant proteins between multiple sclerosis patients and controls using iTRAQ and SID-SRM.
Pages
« first
‹ previous
…
251
252
253
254
255
256
257
258
259
…
next ›
last »